GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Change In Other Working Capital

NewAmsterdam Pharma Co NV (FRA:KH6) Change In Other Working Capital : €-5.04 Mil (TTM As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is NewAmsterdam Pharma Co NV Change In Other Working Capital?

NewAmsterdam Pharma Co NV's Change In Other Working Capital for the quarter that ended in Mar. 2025 was €-2.76 Mil. It means NewAmsterdam Pharma Co NV's Other Working Capital declined by €2.76 Mil from Dec. 2024 to Mar. 2025 .

NewAmsterdam Pharma Co NV's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was €-3.78 Mil. It means NewAmsterdam Pharma Co NV's Other Working Capital declined by €3.78 Mil from Dec. 2023 to Dec. 2024 .

NewAmsterdam Pharma Co NV Change In Other Working Capital Historical Data

The historical data trend for NewAmsterdam Pharma Co NV's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewAmsterdam Pharma Co NV Change In Other Working Capital Chart

NewAmsterdam Pharma Co NV Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
- - 17.40 -7.98 -3.78

NewAmsterdam Pharma Co NV Quarterly Data
Dec20 Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.29 -2.12 -1.61 1.45 -2.76

NewAmsterdam Pharma Co NV Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NewAmsterdam Pharma Co NV Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of NewAmsterdam Pharma Co NV's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

NewAmsterdam Pharma Co NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NewAmsterdam Pharma Co NV (FRA:KH6) » Definitions » Change In Other Working Capital
Comparable Companies
HRMY LGND DNLI CGON KYMR FOLD VCEL ARWR TARS MIRM VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
NAMS:USA KH6:Germany
Address
Gooimeer 2-35, Naarden, NH, NLD, 1411 DC
Website
https://www.newamsterdampharma.com
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

NewAmsterdam Pharma Co NV Headlines

No Headlines